Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

March 12, 2015

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2022

Conditions
Glaucoma
Interventions
DIETARY_SUPPLEMENT

Citicoline

Every subject randomized into this group have to take 2 sachets of Cebrolux 800 (362 mg of citicoline per day), every day, for 3 months.

DIETARY_SUPPLEMENT

Docosahexaenoic Acid (DHA)

Every subject randomized into this group have to take 3 pills of Brudypio 1.5g (1050 mg of DHA per day), every day, for 3 months.

DIETARY_SUPPLEMENT

Citicoline and Docosahexaenoic Acid (DHA)

Every subject randomized into this group have to take 2 sachets of Cebrolux 800 and 3 pills of Brudypio 1.5g per day, every day, for 3 months.

DIETARY_SUPPLEMENT

Vitamin C

Every subject randomized into this group have to take 1 pills of Vitamin C (500 mg per day), every day, for 3 months.

Trial Locations (1)

08022

Institut Catala de Retina, Barcelona

All Listed Sponsors
lead

Institut Catala de Retina

OTHER

NCT05527106 - Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma | Biotech Hunter | Biotech Hunter